Skip to content

Insider · CIK 0001873465

Martell Christopher

Reports to the SEC for 1 company · NEEDHAM, MA

Transactions

13

Companies

1

Filings

9

CIK

0001873465

Forms 4 and 5

Insider transactions

13 trades
DateCompanyValue
2026-06-23CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2025-06-25CADLCandel Therapeutics, Inc.A Award+$520K
2025-06-17CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2024-06-26CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2023-06-28CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2022-12-09CADLCandel Therapeutics, Inc.P Purchase+$46K
2022-12-09CADLCandel Therapeutics, Inc.P Purchase+$46K
2022-12-08CADLCandel Therapeutics, Inc.P Purchase+$5,124
2022-12-08CADLCandel Therapeutics, Inc.P Purchase+$5,124
2022-10-13CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2021-07-29CADLCandel Therapeutics, Inc.C Conversion—
2021-07-29CADLCandel Therapeutics, Inc.P Purchase+$1M
2021-07-29CADLCandel Therapeutics, Inc. · Series B Preferred StockC Conversion—

Recent filings

9

Companies

1

Address

C/O CANDEL THERAPEUTICS, INC. 117 KENDRICK ST., SUITE 450

NEEDHAM, MA, 02494